BBOT

BridgeBio Oncology Therapeutics, Inc. Common Stock

BBOT • NASDAQ

BridgeBio Oncology Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Eli Wallace, with a market cap of $710.7M.

CEOEli Wallace
Market Cap$710.7M

Next Earnings

Upcoming earnings announcement for BridgeBio Oncology Therapeutics, Inc. Common Stock

Date
Tuesday, May 26, 2026 (in 2 months)
Timing
Before Market Open (8:21 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.51

Earnings History

Past 2 earnings reports for BridgeBio Oncology Therapeutics, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Mar 5, 2026Q4 2025
-$0.49Est: -$0.66
+25.8%
-
——
Nov 12, 2025Q3 2025
-$1.03Est: -$0.37
-178.4%
-
——

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Q1 2026 Earnings - Capbase